Sangam Health Care Products Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve 1. Unaudited financial ....
Awaiting price reaction for this filing.
Sangam Health Care Products Ltd has informed BSE that its Board of Directors will meet on Friday, 13 February 2026 at the registered office. The main items on the agenda are approval of the unaudited financial results for the quarter ended 31 December 2025 and the Limited Review Report for that period. Any other business with the Chair's permission may also be discussed. The letter is signed by Managing Director D. Bhagat Reddy and filed under SEBI LODR Regulations 29(1)(a) and 33. No financial numbers, estimates, or forward-looking details are included in this intimation — those will come in the actual results announcement.
This is a routine pre-results intimation and is unlikely to move the stock on its own. Investors should watch for the actual Q3 FY26 numbers on or after 13 February 2026, as the unaudited results and limited review report will be the first concrete update on the company's quarterly performance.